![Atopic dermatitis of the face and neck in an 18-year-old woman before... | Download Scientific Diagram Atopic dermatitis of the face and neck in an 18-year-old woman before... | Download Scientific Diagram](https://www.researchgate.net/profile/Alexander-Kapp/publication/12393210/figure/fig1/AS:352445109686277@1461040870331/Atopic-dermatitis-of-the-face-and-neck-in-an-18-year-old-woman-before-treatment-A-and-B_Q320.jpg)
Atopic dermatitis of the face and neck in an 18-year-old woman before... | Download Scientific Diagram
![Comparison of the efficacy and safety of 0.1% tacrolimus ointment and 0.1% mometasone furoate cream for adult vitiligo: A single-blinded pilot study - ScienceDirect Comparison of the efficacy and safety of 0.1% tacrolimus ointment and 0.1% mometasone furoate cream for adult vitiligo: A single-blinded pilot study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1027811716300271-gr1.jpg)
Comparison of the efficacy and safety of 0.1% tacrolimus ointment and 0.1% mometasone furoate cream for adult vitiligo: A single-blinded pilot study - ScienceDirect
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://gnq.fic.mybluehost.me/jcad-online-backup/wp-content/uploads/ShahFeb2020Figure12.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Tacrolimus Ointment 0.1% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE Rx Only Prescribing Information See boxed WARNING concerning long-term safety of topical calcineurin inhibitors Tacrolimus Ointment 0.1% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE Rx Only Prescribing Information See boxed WARNING concerning long-term safety of topical calcineurin inhibitors](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=30g---label.jpg&id=736561)